000 | 00929 a2200265 4500 | ||
---|---|---|---|
005 | 20250513092840.0 | ||
264 | 0 | _c19960905 | |
008 | 199609s 0 0 eng d | ||
022 | _a0964-3397 | ||
024 | 7 |
_a10.1016/s0964-3397(96)81728-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMacConnachie, A M | |
245 | 0 | 0 |
_aClarithromycin (klaricid, Abbott). _h[electronic resource] |
260 |
_bIntensive & critical care nursing _cFeb 1996 |
||
300 |
_a60-1 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xeconomics |
650 | 0 | 4 |
_aClarithromycin _xeconomics |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
773 | 0 |
_tIntensive & critical care nursing _gvol. 12 _gno. 1 _gp. 60-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0964-3397(96)81728-9 _zAvailable from publisher's website |
999 |
_c8693316 _d8693316 |